The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Chalcone Derivatives: Role in Anticancer Therapy
Open accessAbstract
Chalcones (1,3-diaryl-2-propen-1-ones) are precursors for flavonoids and isoflavonoids, which are common simple chemical scaffolds found in many naturally occurring compounds. Many chalcone derivatives were also prepared due to their convenient synthesis. Chalcones as weandhetic analogues have attracted much interest due to their broad biological activities with clinical potentials against various diseases, particularly for antitumor activity. The chalcone family has demonstrated potential in vitro and in vivo activity against cancers via multiple mechanisms, including cell cycle disruption, autophagy regulation, apoptosis induction, and immunomodulatory and inflammatory mediators. It represents a promising strategy to develop chalcones as novel anticancer agents. In addition, the combination of chalcones and other therapies is expected to be an effective way to improve anticancer therapeutic efficacy. However, despite the encouraging results for their response to cancers observed in clinical studies, a full description of toxicity is required for their clinical use as safe drugs for the treatment of cancer. In this review, we will summarize the recent advances of the chalcone family as potential anticancer agents and the mechanisms of action. Besides, future applications and scope of the chalcone family toward the treatment and prevention of cancer are brought out.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866 · cited 1×
“Numerous studies have focused on the ability of chalcone to mediate resistance to conventional chemotherapeutic drugs by modulating multidrug efflux transporters, which are essential components of intracellular drug accumulation [172,173].”
BackgroundSchopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540 · cited 1×
“[219] have shown that synthetic chalcones can have a heat-shock protein 90 (HSP90)-induced inhibitory effect, which opens new perspectives into cancer treatment through the destabilization proteins by which cancer cells survive and multiply (tumorigenesis) [220].”
BackgroundChalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,463
Hybrid Molecules with a Dual Mode of Action: Dream or Reality?
Meunier, B. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000843 · Cited by 929
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Drugs from the deep: Marine natural products as drug candidates
Haefner, B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02713-2 · Cited by 740
Recent developments in biological activities of chalcones: A mini review
Singh, P., Anand, A., & Kumar, V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.033 · Cited by 710
Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives
Kumari, A., & Singh, R. K. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103021 · Cited by 583
Exploring Pharmacological Significance of Chalcone Scaffold: A Review
K. Sahu, N., S. Balbhadra, S., Choudhary, J., & V. Kohli, D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803414132 · Cited by 582
Indole: A privileged scaffold for the design of anti-cancer agents
Wan, Y., Li, Y., Yan, C., Yan, M., & Tang, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111691 · Cited by 516
Hybrid molecules: The privileged scaffolds for various pharmaceuticals
Shaveta, Mishra, S., & Singh, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.039 · Cited by 508
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack
Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 466
Chalcone Derivatives: Promising Starting Points for Drug Design
Gomes, M., Muratov, E., Pereira, M., Peixoto, J., Rosseto, L., Cravo, P., Andrade, C., & Neves, B. (2017) · Molecules · doi:10.3390/molecules22081210 · Cited by 418
Naturally occurring chalcones and their biological activities
Rozmer, Z., & Perjési, P. (2016) · Phytochemistry Reviews · doi:10.1007/s11101-014-9387-8 · Cited by 382
Salehi, B., Quispe, C., Chamkhi, I., El Omari, N., Balahbib, A., Sharifi-Rad, J., Bouyahya, A., Akram, M., Iqbal, M., Docea, A. O., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592654 · Cited by 351
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2005) · Natural Product Reports · doi:10.1039/b415080p · Cited by 350
Trends in Utilization of the Pharmacological Potential of Chalcones
Batovska, D., & Todorova, I. (2010) · Current Clinical Pharmacology · doi:10.2174/157488410790410579 · Cited by 343
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Dadashpour, S., & Emami, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.065 · Cited by 343
The role of chalcones in suppression of NF-κB-mediated inflammation and cancer
Yadav, V. R., Prasad, S., Sung, B., & Aggarwal, B. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.006 · Cited by 339
Zeng, J., Chen, Y., Ding, R., Feng, L., Fu, Z., Yang, S., Deng, X., Xie, Z., & Zheng, S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0895-5 · Cited by 319
The Roles of MDM2 and MDMX in Cancer
Karni-Schmidt, O., Lokshin, M., & Prives, C. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040349 · Cited by 296
Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents
Sashidhara, K. V., Kumar, A., Kumar, M., Sarkar, J., & Sinha, S. K. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.116 · Cited by 290
Baldwin, A. S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01095.x · Cited by 277
Kim, J.-Y., Park, S. J., Yun, K.-J., Cho, Y.-W., Park, H.-J., & Lee, K.-T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.032 · Cited by 265
Dihydroartemisinin: A Potential Natural Anticancer Drug
Dai, X., Zhang, X., Chen, W., Chen, Y., Zhang, Q., Mo, S., & Lu, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.50364 · Cited by 252
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
Wong, Y. K., Xu, C., Kalesh, K. A., He, Y., Lin, Q., Wong, W. S. F., Shen, H., & Wang, J. (2017) · Medicinal Research Reviews · doi:10.1002/med.21446 · Cited by 240
Wang, Z., Wang, N., Han, S., Wang, D., Mo, S., Yu, L., Huang, H., Tsui, K., Shen, J., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068566 · Cited by 233
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Jin, J., Qiu, S., Wang, P., Liang, X., Huang, F., Wu, H., Zhang, B., Zhang, W., Tian, X., Xu, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1351-4 · Cited by 225
Bisht, K., Wagner, K.-H., & Bulmer, A. C. (2010) · Toxicology · doi:10.1016/j.tox.2009.11.008 · Cited by 222
Relevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Shanmugam, M. K., Warrier, S., Kumar, A. P., Sethi, G., & Arfuso, F. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170713094319 · Cited by 213
Maximizing the Therapeutic Potential of HSP90 Inhibitors
Butler, L. M., Ferraldeschi, R., Armstrong, H. K., Centenera, M. M., & Workman, P. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0234 · Cited by 208
Diverse Molecular Targets for Chalcones with Varied Bioactivities
Zhou, B. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000291 · Cited by 195
Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700890200 · Cited by 189
Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P., Krishnan, S., Guha, S., & Aggarwal, B. B. (2009) · Blood · doi:10.1182/blood-2008-04-151944 · Cited by 167
Yan, J., Chen, J., Zhang, S., Hu, J., Huang, L., & Li, X. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00021 · Cited by 164
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Stein, Y., Rotter, V., & Aloni-Grinstein, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246197 · Cited by 162
Medicinal Plants in the Prevention and Treatment of Colon Cancer
Aiello, P., Sharghi, M., Mansourkhani, S. M., Ardekan, A. P., Jouybari, L. M., Daraei, N., Peiro, K., Mohamadian, S., Rezaei, M., Heidari, M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2075614 · Cited by 160
Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents
Fröhlich, T., Çapcı Karagöz, A., Reiter, C., & Tsogoeva, S. B. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01380 · Cited by 159
Isobavachalcone, a Chalcone Constituent of Angelica keiskei, Induces Apoptosis in Neuroblastoma
Nishimura, R., Tabata, K., Arakawa, M., Ito, Y., Kimura, Y., Akihisa, T., Nagai, H., Sakuma, A., Kohno, H., & Suzuki, T. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1878 · Cited by 157
Gao, F., Huang, G., & Xiao, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21698 · Cited by 155
Abou‐Zied, H. A., Youssif, B. G. M., Mohamed, M. F. A., Hayallah, A. M., & Abdel‐Aziz, M. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102997 · Cited by 153
Wang, J., Qi, Q., Zhou, W., Feng, Z., Huang, B., Chen, A., Zhang, D., Li, W., Zhang, Q. H., Jiang, Z., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1501133 · Cited by 152
Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation
Moon, D.-O., Kim, M.-O., Choi, Y. H., Hyun, J. W., Chang, W. Y., & Kim, G.-Y. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.07.002 · Cited by 151
Inhibitory kappa B kinases as targets for pharmacological regulation
Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R. J., & Paul, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01608.x · Cited by 150
A comprehensive review of chalcone derivatives as antileishmanial agents
Palmeira-Mello, M. V., Abrahim-Vieira, B. D. A., Domingos, T. F. S., de Jesus, J. B., de Sousa, A. C. C., Rodrigues, C. R., & de Souza, A. M. T. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.047 · Cited by 145
Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Jandial, D., Blair, C., Zhang, S., Krill, L. S., Zhang, Y., & Zi, X. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666140122160515 · Cited by 137
Akihisa, T., Tokuda, H., Hasegawa, D., et al. (2006) · Journal of Natural Products · doi:10.1021/np058080d · Cited by 136
Li, W., Xu, F., Wen, S., Sun, H., Yao, H., Ma, C., Xu, S., Yao, H., Zhu, Z., Yang, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01755 · Cited by 135
Antiangiogenic Effect of Flavonoids and Chalcones: An Update
Mirossay, L., Varinská, L., & Mojžíš, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010027 · Cited by 134
Liao, Y., Tan, R., Li, J., Liu, T., Zhong, X., Yan, Y., Yang, J., Lin, X., Jun-ming, F., & Wang, L. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s243420 · Cited by 134
Self-citationXanthohumol inhibits angiogenesis by suppressing nuclear factor‐κB activation in pancreatic cancer
Saito, K., Matsuo, Y., Imafuji, H., Okubo, T., Maeda, Y., Sato, T., Shamoto, T., Tsuboi, K., Morimoto, M., Takahashi, H., et al. (2017) · Cancer Science · doi:10.1111/cas.13441 · Cited by 129
Lv, H., Yang, H., Wang, Z., Feng, H., Deng, X., Cheng, G., & Ci, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1543-z · Cited by 124
Kuete, V., & Sandjo, L. P. (2012) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-012-1142-7 · Cited by 121
Muchtaridi, M., Syahidah, H. N., Subarnas, A., Yusuf, M., Bryant, S. D., & Langer, T. (2017) · Pharmaceuticals · doi:10.3390/ph10040081 · Cited by 121
Kode, J., Kovvuri, J., Nagaraju, B., Jadhav, S., Barkume, M. S., Sen, S., Kasinathan, N. K., Chaudhari, P. R., Mohanty, B. S., Gour, J., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104447 · Cited by 121
Wang, N., Wang, Z., Peng, C. Y., You, J., Shen, J., Han, S., & Chen, J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu187 · Cited by 116
Wang, G., Li, C., He, L., Lei, K., Wang, F., Pu, Y., Yang, Z., Cao, D., Ma, L., Chen, J., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.028 · Cited by 115
A Systematic Review on Anti-diabetic Properties of Chalcones
Rocha, S., Ribeiro, D., Fernandes, E. G. R., & Freitas, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181001112226 · Cited by 115
Wang, C., Chen, Y., Wang, Y., Liu, X., Liu, Y., Li, Y., Chen, H., Fan, C., Wu, D., & Yang, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1361-2 · Cited by 114
An Update on Antitumor Activity of Naturally Occurring Chalcones
Zhang, E.-H., Wang, R., Guo, S., & Liu, B. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/815621 · Cited by 112
Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities
Bail, J.-C. L., Pouget, C., Fagnère, C., Basly, J. P., Chulia, A.-J., & Habrioux, G. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00974-7 · Cited by 109
Hseu, Y., Lee, M., Wu, C., Cho, H., Lin, K., Lai, G., Wang, S., Kuo, Y., Kumar, K. J. S., & Yang, H. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf205053r · Cited by 105
Potential of butein, a tetrahydroxychalcone to obliterate cancer
Padmavathi, G., Rathnakaram, S. R., Monisha, J., Bordoloi, D., Roy, N. K., & Kunnumakkara, A. B. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.08.015 · Cited by 100
Ahmed, F. F., El‐Hafeez, A. A. A., Abbas, S. H., Abdelhamid, D. S., & Abdel‐Aziz, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.073 · Cited by 94
Wani, Z. A., Guru, S. K., Rao, A., Sharma, S., Mahajan, G., Behl, A., Kumar, A., Sharma, P. R., Kamal, Ä., Bhushan, S., et al. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.11.016 · Cited by 91
Boumendjel, A., Leer, A. M., Champelovier, P., Allegro, D., Muhammad, D., Souard, F., Derouazi, M., Peyrot, V., Toussaint, B., & Boutonnât, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-242 · Cited by 89
Feng, L., Xu, Z. G., Chang, L., Li, C., Yan, X., Gao, C., Ding, C., Zhao, F. J., Shi, F., & Wu, X. (2019) · Medicinal Research Reviews · doi:10.1002/med.21643 · Cited by 86
Chalcone hybrids and their antimalarial activity
Cheng, P., Yang, L., Huang, X., Wang, X., & Gong, M. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.201900350 · Cited by 86
Kraege, S., Stefan, K., Juvale, K., Ross, T., Willmes, T., & Wiese, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.067 · Cited by 82
Lee, D., & Jeong, G. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13569 · Cited by 82
Cancer drug resistance: A fleet to conquer
Hussain, S., Singh, A., Nazir, S. U., Tulsyan, S., Khan, A., Kumar, R., Bashir, N., Tanwar, P., & Mehrotra, R. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28782 · Cited by 82
Inhibition of TNFα-induced activation of nuclear factor κB by kava (Piper methysticum) derivatives
Folmer, F., Blasius, R., Morceau, F., Tabudravu, J., Dicato, M., Jaspars, M., & Diederich, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.032 · Cited by 80
Fathi, M. A. A., El‐Hafeez, A. A. A., Abdelhamid, D. S., Abbas, S. H., Montano, M. M., & Abdel‐Aziz, M. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.032 · Cited by 80
Iheagwam, F. N., Ogunlana, O. O., Ogunlana, O. E., Isewon, I., & Oyelade, J. O. (2019) · Bioinformatics and Biology Insights · doi:10.1177/1177932218821371 · Cited by 80
Rasheed, Z., Akhtar, N., Khan, A., Khan, K. A., & Haqqi, T. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.165209 · Cited by 79
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091
Canela, M., Noppen, S., Bueno, O., Prota, A. E., Bargsten, K., Sáez-Calvo, G., Jimeno, M. L., Benkheil, M., Ribatti, D., Velázquez, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9527 · Cited by 78
Padhyé, S., Ahmad, A., Oswal, N., Dandawate, P. R., Rub, R. A., Deshpande, J., Swamy, K. V., & Sarkar, F. H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.128 · Cited by 76
Lindamulage, I. K. S., Vu, H.-Y. T., Karthikeyan, C., Knockleby, J., Lee, Y.-F., Trivedi, P., & Lee, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-10972-0 · Cited by 74
Peng, F., Tang, H., Liu, P., Shen, J., Guan, X., Xie, X., Gao, J., Xiong, L., Jia, L., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08422-y · Cited by 72
Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth
Chen, H.-Y., Huang, T., Shieh, T., Wu, C., Lin, L.-C., & Hsia, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102025 · Cited by 70
Sun, X., Zhang, J., Wang, Z., Liu, B., Zhu, S., Zhu, L., & Peng, B. (2019) · Theranostics · doi:10.7150/thno.33376 · Cited by 70
Lin, P., Chiang, Y., Shieh, T., Chen, H.-Y., Shih, C., Wang, T., Wang, K.-L., Huang, T., Hong, Y.-H., Li, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030228 · Cited by 70
Ng, H.-L., Ma, X., Chew, E., & Chui, W. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01253 · Cited by 69
Zhang, B., Lai, Y., Li, Y., Shu, N., Wang, Z., Wang, Y., Li, Y., & Chen, Z. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.053 · Cited by 69
Mohamed, M. F. A., Shaykoon, M. S. A., Abdelrahman, M. H., Elsadek, B., Aboraia, A. S., & Abuo‐Rahma, G. E. A. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.03.005 · Cited by 68
Wang, L., Chen, G., Lu, X., Wang, S., Han, S., Li, Y., Ping, G., Jiang, X., Li, H., Yang, J., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.036 · Cited by 64
Ferrocenyl chalcone derivatives as possible antimicrobial agents
Henry, E. J., Bird, S. J., Gowland, P., Collins, M., & Cassella, J. P. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0280-y · Cited by 64
Lee, Y. H., Jeon, S., Kim, S. H., Kim, C., Lee, S., Koh, D., Lim, Y., Ha, K., & Shin, S. Y. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.6.042 · Cited by 61
Bagul, C., Rao, G. K., Makani, V. K. K., Tamboli, J. R., Pal‐Bhadra, M., & Kamal, A. (2017) · MedChemComm · doi:10.1039/c7md00193b · Cited by 61
A Synthetic Chalcone as a Potent Inducer of Glutathione Biosynthesis
Kachadourian, R., Day, B. J., Pugazhenti, S., Franklin, C. C., Genoux‐Bastide, E., Mahaffey, G., Gauthier, C., Pietro, A. D., & Boumendjel, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2016073 · Cited by 59
Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters
Smit, F. J., van Biljon, R., Birkholtz, L., & N’Da, D. D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.016 · Cited by 59
Molecular chemotherapeutic potential of butein: A concise review
Jayasooriya, R. G. P. T., Molagoda, I. M. N., Park, C., Jeong, J.-W., Choi, Y. H., Moon, D., Kim, M.-O., & Kim, G. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.12.028 · Cited by 59
Li, Y., Qin, X., Li, P., Zhang, H., Lin, T., Miao, Z., & Ma, S. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s192681 · Cited by 59
Singh, N., Sarkar, J., Sashidhara, K. V., Ali, S., & Sinha, S. K. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0975-2 · Cited by 58
Gaur, R., Pathania, A. S., Malik, F. A., Bhakuni, R. S., & Verma, R. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.035 · Cited by 57
New indole-based chalconoids as tubulin-targeting antiproliferative agents
Mirzaei, H., Shokrzadeh, M., Modanloo, M., Ziar, A., Riazi, G. H., & Emami, S. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.09.005 · Cited by 57
Silbermann, K., Shah, C. P., Sahu, N. U., Juvale, K., Stefan, S. M., Kharkar, P. S., & Wiese, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.019 · Cited by 56
Elkhalifa, D. H., Siddique, A. B., Qusa, M. H., Cyprian, F. S., Sayed, K. A. E., Alali, F. Q., Moustafa, A. A., & Khalil, A. A. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111954 · Cited by 56
Synthesis, structural characterization, and cytotoxic evaluation of chalcone derivatives
Bandeira, P. N., Lemos, T. L. G., dos Santos, H. S., de Carvalho, M. C. S., Pinheiro, D. P., de Moraes, M. O., Pessoa, C., Nepomuceno, F. W. A. B., Rodrigues, T. H. S., Ribeiro, P. R. V., et al. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02434-1 · Cited by 55
Yuan, X., Li, T., Xiao, E.-L., Zhao, H., Li, Y., Fu, S., Gan, L., Wang, Z., Zheng, Q., & Wang, Z. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.030 · Cited by 55
Synthesis of novel 1,2,3-triazole based artemisinin derivatives and their antiproliferative activity
Kapkoti, D. S., Singh, S., Luqman, S., & Bhakuni, R. S. (2018) · New Journal of Chemistry · doi:10.1039/c7nj04271j · Cited by 52
Li, K., Zheng, Q., Chen, X., Wang, Y., Wang, D., & Wang, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1915828 · Cited by 52
Self-citationAntiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells
dos Santos, M. B., Anselmo, D. B., de Oliveira, J. G., Jardim‐Perassi, B. V., Monteiro, D. A., SILVA, G. H. D. O., Gomes, E., Fachin, A. L., Marins, M., Zuccari, D. A. P. D. C., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1615485 · Cited by 52
Ngo, T.-D., Tran, T., Le, M.-T., & Thai, K. (2016) · Molecular Diversity · doi:10.1007/s11030-016-9688-5 · Cited by 51
Kwon, S. J., Park, S. Y., Kwon, G. T., Lee, K. W., Kang, Y., Choi, M., Yun, J. W., Jeon, J., Jun, J. G., & Park, J. H. Y. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0012 · Cited by 50
Trans-chalcone increases p53 activity via DNAJB1/HSP40 induction and CRM1 inhibition
SILVA, G. H. D. O., Marins, M., Chaichanasak, N., Yoon, Y., Fachin, A. L., Pinhanelli, V. C., Regasini, L. O., dos Santos, M. B., Ayusso, G. M., Marques, B. D. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202263 · Cited by 48
Marković, V. R., Debeljak, N., Stanojković, T., Kolundžija, B., Sladić, D. M., Vujčić, M. T., Janović, B. S., Tanić, N., Perović, M., Tešić, V., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.055 · Cited by 47
Predes, D., Oliveira, L. F. S., Ferreira, L. S. S., Maia, L. A., Delou, J. M. D. A., Faletti, A., de Oliveira, I. S., Amado, N. G., Reis, A. H., Fraga, C. A. M., et al. (2019) · Cancers · doi:10.3390/cancers11121968 · Cited by 47
Mphahlele, M. J., Maluleka, M. M., Parbhoo, N., & Malindisa, S. T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092552 · Cited by 46
Moon, D., Choi, Y. H., Moon, S., Kim, W., & Kim, G. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.08.002 · Cited by 45
George, R. F., Kandeel, M. M., El-Ansary, D. Y., & Kerdawy, A. M. E. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103780 · Cited by 45
Parveen, Z., Brunhofer, G., Jabeen, I., Erker, T., Chiba, P., & Ecker, G. F. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.005 · Cited by 44
Yin, H., Dong, J., Cai, Y., Shi, X., Wang, H., Liu, G., Tang, Y., Liu, J., & Ma, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.053 · Cited by 44
Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells
Badroon, N. A., Majid, N. B. A., & Alshawsh, M. A. (2020) · Nutrients · doi:10.3390/nu12061757 · Cited by 43
Lin, Y.-T., Zhang, M., Lu, Q., Xie, J., Wu, J., & Chen, C. (2019) · Aging · doi:10.18632/aging.102288 · Cited by 42
Anti-cancer activity oftrans-chalcone in osteosarcoma: Involvement of Sp1 and p53
SILVA, G. H. D. O., Marins, M., Fachin, A. L., Lee, S., & Baek, S. J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22386 · Cited by 41
Cerezo, A. B., Winterbone, M. S., Moyle, C. W. A., Needs, P. W., & Kroon, P. A. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500407 · Cited by 41
Lee, Y., Kim, B. S., Ahn, S., Koh, D., Lee, Y. H., Shin, S. Y., & Lim, Y. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.08.003 · Cited by 41
Wang, C., Li, Y., Chen, H., Zhang, J., Zhang, J., Qin, T., Duan, C., Chen, X., Liu, Y., Zhou, X., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.030 · Cited by 41
Self-citationGu, X., Ren, Z., Tang, X., Peng, H., Yuan-fang Ma, A., Lai, Y., Peng, S., & Zhang, Y. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.050 · Cited by 40
Seba, V., SILVA, G. H. D. O., dos Santos, M. B., Baek, S. J., França, S. D. C., Fachin, A. L., Regasini, L. O., & Marins, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092838 · Cited by 39
Han, X., Peng, B., Xiao, B.-B., Cao, S.-L., Yang, C.-R., Wang, W., Wang, F., Li, H., Yuan, X., Shi, R., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.034 · Cited by 39
Self-citationLi, X., Pham, V., Tippin, M., Fu, D., Rendon, R., Song, L., Uchio, E., Hoang, B. H., & Zi, X. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0338-2 · Cited by 39
Wu, C., Lusvarghi, S., Hsiao, S.-H., Liu, T.-C., Li, Y., Huang, Y.-H., Hung, T., & Ambudkar, S. V. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01022 · Cited by 39
Zhang, S., Li, T., Zhang, Y., Xu, H., Li, Y., Zi, X., Yu, H., Li, J., Jin, C., & Liu, H. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.08.023 · Cited by 37
Self-citationButein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity
Zhou, Y., Li, M., Yu, X., Liu, T., Li, T. X., Zhou, L. Q., Liu, W., Li, W., & Gao, F. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25334 · Cited by 36
Wang, T., Chen, Z.-Z., Xie, P., Zhang, W., Du, M., Liu, Y., Zhu, H., & Guo, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.033 · Cited by 36
Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones
Jeon, K., Yu, H.-B., Kwak, S. Y., Kwon, Y., & Na, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.051 · Cited by 35
Pérès, B., Nasr, R., Zarioh, M., Lecerf-Schmidt, F., Pietro, A. D., Baubichon-Cortay, H., & Boumendjel, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.064 · Cited by 35
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
Cai, C., Zhang, W., Wang, J., Lei, Z., Zhang, Y., Wang, Y., Gupta, P., Tan, C., Wang, B., & Chen, Z. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113848 · Cited by 35
Ma, Y., Xu, B., Yu, J. H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062216 · Cited by 34
Ng, H.-L., Chen, S., Chew, E., & Chui, W. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.002 · Cited by 33
Ashraf, R., Hamidullah, Hasanain, M., Pandey, P., Maheshwari, M., Singh, L., Siddiqui, M. Q., Konwar, R., Sashidhara, K. V., & Sarkar, J. (2017) · Scientific Reports · doi:10.1038/srep45287 · Cited by 33
Li, B., Xu, N., Wan, Z., Ma, L., Li, H., Cai, W., Chen, X., Huang, Z., & He, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7090 · Cited by 32
Self-citationCardamonin attenuates chronic inflammation and tumorigenesis in colon
Hou, S., Yuan, Q., Yu, N., Liu, B., Huang, G., & Yuan, X. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1673620 · Cited by 32
Siqueira, E. D. S., Concato, V. M., Tomiotto‐Pellissier, F., Silva, T. F., Bortoleti, B. T. D. S., Gonçalves, M. D., Costa, I. N., Verri, W. A., Jr., Pavanelli, W. R., Panis, C., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153373 · Cited by 32
Sung, B., Cho, S., Liu, M., & Aggarwal, B. B. (2010) · International Journal of Cancer · doi:10.1002/ijc.25868 · Cited by 30
Gan, F.-F., Zhang, R., Ng, H.-L., Karuppasamy, M., Seah, W., Yeap, W. H., Ong, S., Hadadi, É., Wong, S. C., Chui, W., et al. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.04.003 · Cited by 29
Xiang, S., Zeng, H., Xia, F., Ji, Q., Xue, J., Ren, R., Que, F.-C., & Zhou, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118598 · Cited by 28
Jeong, C., Park, H. B., Jang, W., Jung, S. H., & Seo, Y. H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.034 · Cited by 27
Ruibin, J., Jin, B., Wan, D., Jianguo, F., & Gu, L. (2020) · Aging · doi:10.18632/aging.104184 · Cited by 27
Qiu, H., Wang, F., Wang, X., Wang, X., Sun, W., Qi, J., Pang, Y., Yang, R., Lu, G., Wang, X., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700001 · Cited by 26
Shi, J., Chen, Y., Chen, W., Tang, C., Zhang, H., Chen, Y., Yang, X. H., Xu, Z., Wei, J., & Chen, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13719 · Cited by 26
Wang, L. ‐., Li, H. ‐., Li, M., Wang, S., Jiang, X. ‐., Li, Y., Ping, G.-F., Cao, Q., Liu, X., Fang, W., et al. (2015) · Cell Proliferation · doi:10.1111/cpr.12226 · Cited by 25
Nedungadi, D., Binoy, A., Nanjan, P., Nair, B. G., & Mishra, N. (2020) · Cell Biology International · doi:10.1002/cbin.11480 · Cited by 23
Anti‐Tumor Activity of New Artemisinin–Chalcone Hybrids
Xie, L., Zhai, X., Liu, C., Li, P., Li, Y., Guo, G., & Gong, P. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201000391 · Cited by 22
ElMonaem, H. S. A., Abdel-Aziz, N. I., Morsy, M. A., et al. (2018) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2018.8510 · Cited by 18
Lee, J. A., Kim, D. J., & Hwang, O. (2019) · PubMed Central · doi:10.14348/molcells.2019.0129 · Cited by 18
Luca, D. D., & Lauritano, C. (2020) · Biology · doi:10.3390/biology9050110 · Cited by 18
Song, Y., Guan, X., Weng, Z.-M., et al. (2020) · Food & Function · doi:10.1039/d0fo02140g · Cited by 16
Li, J., Zheng, L., Wang, R., Sun, D., Liang, S., Wu, J., Liu, Y., Tian, X., Li, T., Yang, Y., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s259432 · Cited by 12
Self-citationJobst, B., Weigl, J., Michl, C., Vivarelli, F., Pinz, S., Amslinger, S., & Rascle, A. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0148 · Cited by 10
The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum
Tugcu, G., Kırmızıbekmez, H., & Aydın, A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111663 · Cited by 9
Cited by
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
Shen, N., Wang, T., Gan, Q., Liu, S., Wang, L., & Jin, B. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.132531 · Cited by 2,134
Metadata
- Authors
- Ouyang, Y., Li, J., Chen, X., Fu, X., Sun, S., & Wu, Q.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2021-06-16
- Volume
- 11
- Issue
- 6
- Pages
- 894
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W3173697795
- Cited by
- 399
- References
- 158
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.